Divis Laboratories Ltd

  • BSE Code : 532488
  • NSE Symbol : DIVISLAB
  • ISIN : INE361B01024
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS

up-arrow 5,947.00 -50.50(-0.84%)

Open Price ()

5,960.00

Prev. Close ()

5,997.50

Volume (No’s)

492,229

Market Cap ()

157,874.16

Low Price ()

5,901.50

High Price ()

5,990.00

 

Corporate Announcement

12-Feb-2026 Divi's Laboratories Limited - Copy of Newspaper Publication
11-Feb-2026 Divi's Laboratories Limited - Outcome of Board Meeting
03-Feb-2026 Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
31-Dec-2025 Divi's Laboratories Limited - Trading Window
07-Nov-2025 Divi's Laboratories Limited - Appointment

Stock Summary

Market Cap(₹Cr.)

157,862.22

P/E (TTM)

61.36

Book value ()

578.26

Div Yield (%)

0.5

EPS (TTM)

96.91

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

6,060.00

Resistance 2

6,122.50

Support 1

5,935.00

Support 2

5,872.50

Moving Average

30 Days

6,213.12

50 Days

6,170.19

100 Days

6,320.21

200 Days

6,353.01

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Divis Laboratories Ltd 157,862.22 61.36 10.27 3332 0.5 96.91
Sun Pharmaceutical Indust.. 421,647.13 96.61 17.11 7162.05 0.91 18.19
Torrent Pharmaceuticals L.. 142,845.97 63.96 14.42 3583.06 0.14 65.99
Lupin Ltd 105,731.81 19.12 3.81 5569.31 0.52 120.95
Dr Reddys Laboratories Lt.. 104,720.24 22.57 3.31 8385.2 0.64 55.59

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 54504232 20.53
Total Institutions 51178456 19.28
Total Govt Holding 3236 0.00
Total Non Promoter Corporate Holding 3185851 1.20
Total Promoters 137735090 51.88
Total Public & others 18861715 7.11
Total 265468580 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. It is among the largest pharmaceutical companies in India with a portfolio of approx. 160 products across diverse therapeutic areas. Presently, it has 6 manufacturing facilities and market presence across several countries.

The company has two subsidiaries M/s. Divis Laboratories (USA) Inc., in the United States of America and M/s. Divi's Laboratories Europe AG in Switzerland for marketing its Nutra products and to provide a greater reach to customers within these regions. The company has Research Centers at Sanathnagar, Hyderabad and at the manufacturing sites. Res...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew